Regardless of residual β-cell function, liraglutide (1.2 mg daily) effectively lowered insulin dosage requirements, while maintaining or enhancing glycemic control in a limited study of 29 patients with T1D [21]. Here, INS is linked to type 1 diabetes mellitus.